Total Payments
$451.15
2023 Payments
$65.14
Companies
11
Transactions
33
Medicare Patients
1,584
Medicare Billing
$94,057
Payment Breakdown by Category
Food & Beverage$451.15 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $451.15 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $117.12 | 9 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $92.90 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $48.44 | 3 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $36.04 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $31.88 | 2 | $0 (2022) |
| PFIZER INC. | $27.74 | 2 | $0 (2023) |
| ABBVIE INC. | $25.93 | 2 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $25.66 | 2 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $19.65 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.55 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $65.14 | 4 | Otsuka America Pharmaceutical, Inc. ($19.65) |
| 2022 | $230.57 | 17 | Novo Nordisk Inc ($66.41) |
| 2021 | $111.40 | 9 | Takeda Pharmaceuticals U.S.A., Inc. ($47.96) |
| 2018 | $13.04 | 1 | Merck Sharp & Dohme Corporation ($13.04) |
| 2017 | $31.00 | 2 | GlaxoSmithKline, LLC. ($19.96) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: PSYCHIATRY | ||||||
| 03/02/2023 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: VACCINES | ||||||
| 02/08/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Obesity | ||||||
| 01/18/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Diabetes | ||||||
| 11/16/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $13.47 | General |
| Category: Cardiovascular | ||||||
| 11/09/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Diabetes | ||||||
| 09/28/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.24 | General |
| Category: PSYCHIATRY | ||||||
| 07/27/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Diabetes | ||||||
| 07/06/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: VACCINES | ||||||
| 06/03/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Diabetes | ||||||
| 05/25/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/21/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: RESPIRATORY | ||||||
| 03/25/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: VACCINES | ||||||
| 03/23/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: NEUROSCIENCE | ||||||
| 03/03/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Diabetes | ||||||
| 02/23/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $12.19 | General |
| Category: Cardiovascular | ||||||
| 12/08/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Diabetes | ||||||
| 11/17/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: VACCINES | ||||||
| 11/10/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.15 | General |
| 08/11/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 447 | 584 | $119,441 | $21,994 |
| 2022 | 9 | 425 | 517 | $110,210 | $17,462 |
| 2021 | 9 | 400 | 473 | $102,319 | $31,777 |
| 2020 | 8 | 312 | 338 | $73,151 | $22,825 |
Total Patients
1,584
Total Services
1,912
Medicare Billing
$94,057
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 194 | $47,918 | $8,717 | 18.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 85 | 85 | $33,745 | $4,663 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 84 | $30,492 | $4,493 | 14.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 19 | 23 | $1,863 | $1,198 | 64.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $1,395 | $1,079 | 77.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 81 | 119 | $1,785 | $999.60 | 56.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $525.00 | $509.55 | 97.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 26 | $1,534 | $257.20 | 16.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 23 | $184.00 | $78.43 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 164 | $40,508 | $6,445 | 15.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 91 | 91 | $36,127 | $4,790 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 62 | $22,506 | $3,406 | 15.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $6,380 | $912.95 | 14.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $814.00 | $753.94 | 92.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $490.00 | $471.66 | 96.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 85 | 114 | $1,710 | $337.86 | 19.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 23 | 25 | $1,475 | $259.01 | 17.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 22 | 25 | $200.00 | $86.03 | 43.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 78 | 78 | $30,966 | $11,630 | 37.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 85 | $30,855 | $8,811 | 28.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 105 | $25,935 | $7,105 | 27.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 12 | 12 | $6,960 | $2,256 | 32.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 21 | 22 | $3,300 | $897.68 | 27.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 11 | 11 | $1,430 | $493.24 | 34.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 80 | 111 | $1,665 | $333.00 | 20.0% |
About Dr. Janice Hallit Schnappauf, DO
Dr. Janice Hallit Schnappauf, DO is a Family Medicine healthcare provider based in Branchburg, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720199730.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Janice Hallit Schnappauf, DO has received a total of $451.15 in payments from pharmaceutical and medical device companies, with $65.14 received in 2023. These payments were reported across 33 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($451.15).
As a Medicare-enrolled provider, Hallit Schnappauf has provided services to 1,584 Medicare beneficiaries, totaling 1,912 services with total Medicare billing of $94,057. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Branchburg, NJ
- Active Since 08/31/2006
- Last Updated 05/19/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1720199730
Products in Payments
- TRINTELLIX (Drug) $92.90
- Rybelsus (Drug) $40.80
- Ozempic (Drug) $37.50
- REXULTI (Drug) $31.89
- FARXIGA (Drug) $31.88
- SHINGRIX (Biological) $28.48
- Livalo (Drug) $25.66
- JANUVIA (Drug) $24.08
- BREO (Drug) $19.96
- PREVNAR 13 (Biological) $14.66
- VRAYLAR (Drug) $13.86
- SPIRIVA RESPIMAT (Drug) $13.55
- PREVNAR 20 (Biological) $13.08
- Wegovy (Drug) $12.77
- QULIPTA (Drug) $12.07
- GARDASIL 9 (Biological) $11.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Branchburg
Dr. Lucille Len, M.d, M.D
Family Medicine — Payments: $2,666
Family Medicine $2,666
Dr. Ruby Halper-Erkkila, Md, MD
Family Medicine — Payments: $2,382
Family Medicine $2,382
Mrunalini Gopalam, M.d, M.D
Family Medicine — Payments: $2,102
Family Medicine $2,102
Kathryn Hamilton, Md, MD
Family Medicine — Payments: $1,212
Family Medicine $1,212
Dr. Kristine Cornejo, M.d.,M.p.h, M.D.,M.P.H
Family Medicine — Payments: $1,089
Family Medicine $1,089
Dr. Joseph Lugo, M.d, M.D
Family Medicine — Payments: $386.29
Family Medicine $386.29